ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Virus and Host
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1668727
Isolation, characterization and therapeutic evaluation of phage HHU1 against K2 Klebsiella pneumoniae
Provisionally accepted
- 1Huanghuai University, Zhumadian, China
- 2Zhumadian Central Hospital, Zhumadian, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The prevalence of multidrug-resistant Klebsiella pneumoniae (K. pneumoniae) poses a severe threat to the global economy and public health, driving a resurgence of interest in phage therapy. Consequently, it is imperative to isolate lytic phages against K. pneumoniae with potent bactericidal activity. This study reports the isolation and characterization of the phage HHU1 against K. pneumoniae from hospital sewage, to evaluate its potential for phage therapy. Phage HHU1 has an icosahedral head and retractable tail, similar to members of the Jedunavirus genus. Host range tests revealed that phage HHU1 obligately lysed K. pneumoniae of the K2 serotype. Genome sequencing analysis showed that the genome of phage HHU1 was 47,779 bp in length, with a GC content of 49.2%, encoding 78 open reading frames, and lacked genes associated with lysogeny and virulence. The rapid adsorption (8 min), short latent period (10 min), and high burst size (approximately 134 PFU/cell) indicate robust replication kinetics of phage HHU1. Phage HHU1 remained stably active even after incubation for 6 h at pH 5.0-10.0 and temperature 4-40 ℃. In addition, phage HHU1 with different MOIs can completely inhibit the growth of drug-resistant K. pneumoniae within 8 h in vitro and significantly reduce biofilm formation of drug-resistant bacteria. Notably, treatment with high-dose phage HHU1 (MOI=0.1 and 1) achieved 100% survival in Galleria mellonella larvae infected with drug-resistant K. pneumoniae. These findings demonstrate the potential of phage HHU1 as a promising therapeutic candidate against drug-resistant K. pneumoniae infections.
Keywords: Klebsiella pneumoniae, phage HHU1, Biological properties, phage therapy, drug-resistant
Received: 18 Jul 2025; Accepted: 04 Sep 2025.
Copyright: © 2025 Han, Wen, Sun, Yang, Li and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lei Yang, Huanghuai University, Zhumadian, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.